Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy
Year: 2015
Type: article
Source: Blood
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2550848212
